Richard M. Watanabe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Richard M. Watanabe has a total of 533 co-authors. Here are the top co-authors by number of shared publications:
Thomas A. Buchanan
Diabetes and Obesity Research Institute of USC, Keck School of Medicine of USC, University of Southern California 2 , Los Angeles, CA
13 shared publicationsEnrique Trigo
Department of Medicine, Keck School of Medicine of USC , Los Angeles, CA 90089
7 shared publicationsHooman Allayee
Department of Population and Public Health Sciences, Keck School of Medicine of USC, University of Southern California 1 , Los Angeles, CA
7 shared publicationsJaakko Tuomilehto
Department of Chronic Disease Prevention, Finnish Institute for Health and Welfare, Helsinki, Finland
7 shared publicationsMarkku Laakso
Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland
7 shared publicationsRichard N. Bergman
Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, USA
7 shared publications
Latest Publications
- Open Access
- 11 August 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (3) , e937-e942
Effect of Osteocalcin on Insulin Sensitivity, Insulin Secretion, and β-cell Compensation in Mexican Americans
Context: Previous animal studies show association between osteocalcin (OC) and type 2 diabetes-related quantitative traits (QTs), with some suggesting these effects being mediated by adipokines. Replication in humans has been inconsistent. Objective: We aimed to assess the association between osteocalcin and type 2 diabetes-related QTs and the roles of adipokines on the association between OC and glucose metabolism. Methods: We used data from the BetaGene study, which is a cross-sectional family-based study of Mexican Americans from Los Angeles County. We tested the association between type 2 diabetes-related QTs and OC, including inactive (OC-inactive) and active (OC-active) forms, in 867 Mexican Americans without type 2 diabetes from 342 families. We also assessed the potential mediating effect of adipokines on these relationships. Results: OC-active was negatively associated with insulin sensitivity (SI; P = 2.1 × 10−3) and positively associated with the insulinogenic index (P = 2.8 × 10−3). Acute insulin response was marginally significantly associated with OC-active (P = .07). Measures of β-cell compensation for insulin resistance were not associated with OC. There was no evidence of mediation by adipokines. Conclusion: We conclude OC-active is associated with SI, without mediation by adipokines or body fat. As there was no association with measures of β-cell compensation for insulin resistance, the association between OC-active and insulin secretion reflects the compensatory response to SI.
- 11 August 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (3) , e937-e942
Open AccessEffect of Osteocalcin on Insulin Sensitivity, Insulin Secretion, and β-cell Compensation in Mexican Americans
Context: Previous animal studies show association between osteocalcin (OC) and type 2 diabetes-related quantitative traits (QTs), with some suggesting these effects being mediated by adipokines. Replication in humans has been inconsistent. Objective: We aimed to assess the association between osteocalcin and type 2 diabetes-related QTs and the roles of adipokines on the association between OC and glucose metabolism. Methods: We used data from the BetaGene study, which is a cross-sectional family-based study of Mexican Americans from Los Angeles County. We tested the association between type 2 diabetes-related QTs and OC, including inactive (OC-inactive) and active (OC-active) forms, in 867 Mexican Americans without type 2 diabetes from 342 families. We also assessed the potential mediating effect of adipokines on these relationships. Results: OC-active was negatively associated with insulin sensitivity (SI; P = 2.1 × 10−3) and positively associated with the insulinogenic index (P = 2.8 × 10−3). Acute insulin response was marginally significantly associated with OC-active (P = .07). Measures of β-cell compensation for insulin resistance were not associated with OC. There was no evidence of mediation by adipokines. Conclusion: We conclude OC-active is associated with SI, without mediation by adipokines or body fat. As there was no association with measures of β-cell compensation for insulin resistance, the association between OC-active and insulin secretion reflects the compensatory response to SI.
- 24 April 2025
- Published by American Diabetes Association in Diabetes
- Vol. 74 (7) , 1300-1309
Genetic Variations in GCKR and PNPLA3 Regulate Metabolic Balance Across the Liver
We tested genetic variants in GCK, GCKR, and PNPLA3 in a large sample of self-identified Mexican Americans from the BetaGene Study for association with type 2 diabetes–related phenotypes under the hypothesis that they may regulate metabolic balance across the liver and contribute to hepatic steatosis and insulin resistance. We further tested whether interactions with dietary fructose and total sugar contributes to the observed associations. GCK rs1799831 was not associated with any type 2 diabetes–related phenotypes either alone or with any interaction tested. We replicated previous associations reported for GCKR rs780094 and PNPLA3 rs738409. We also show the interaction between GCKR rs780094 and dietary fructose is associated with both glucose effectiveness and glucose effectiveness at zero insulin, measures reflective of hepatic glucose uptake. We further show the interaction between GCKR rs780094 and PNPLA3 rs738409 is associated with type 2 diabetes–related traits, including insulin sensitivity. We conclude variations in GCKR and PNPLA3 and their interactions with each other and dietary fructose are partial determinants of hepatic fat, likely due to alterations in relative contributions of different metabolic pathways in the liver. These findings point to both GCKR and PNPLA3 as important therapeutic targets to mitigate hepatic metabolic dysfunction. Article Highlights: We examined genetic variation in GCKR and PNPLA3 for association with type 2 diabetes–related traits in Mexican Americans without diabetes. We addressed three questions: Are these loci associated with type 2 diabetes–related traits? Is there interaction between these loci? Is there interaction with dietary sugars? These loci individually, and in an interaction, are associated with type 2 diabetes–related traits; these loci also interact with dietary fructose to alter hepatic glucose uptake. Our findings support the hypothesis that these loci, coupled with dietary fructose and total sugars, alter hepatic metabolic balance and may contribute to hepatic fat and insulin resistance.
- 24 April 2025
- Published by American Diabetes Association in Diabetes
- Vol. 74 (7) , 1300-1309
Genetic Variations in GCKR and PNPLA3 Regulate Metabolic Balance Across the Liver
We tested genetic variants in GCK, GCKR, and PNPLA3 in a large sample of self-identified Mexican Americans from the BetaGene Study for association with type 2 diabetes–related phenotypes under the hypothesis that they may regulate metabolic balance across the liver and contribute to hepatic steatosis and insulin resistance. We further tested whether interactions with dietary fructose and total sugar contributes to the observed associations. GCK rs1799831 was not associated with any type 2 diabetes–related phenotypes either alone or with any interaction tested. We replicated previous associations reported for GCKR rs780094 and PNPLA3 rs738409. We also show the interaction between GCKR rs780094 and dietary fructose is associated with both glucose effectiveness and glucose effectiveness at zero insulin, measures reflective of hepatic glucose uptake. We further show the interaction between GCKR rs780094 and PNPLA3 rs738409 is associated with type 2 diabetes–related traits, including insulin sensitivity. We conclude variations in GCKR and PNPLA3 and their interactions with each other and dietary fructose are partial determinants of hepatic fat, likely due to alterations in relative contributions of different metabolic pathways in the liver. These findings point to both GCKR and PNPLA3 as important therapeutic targets to mitigate hepatic metabolic dysfunction. Article Highlights: We examined genetic variation in GCKR and PNPLA3 for association with type 2 diabetes–related traits in Mexican Americans without diabetes. We addressed three questions: Are these loci associated with type 2 diabetes–related traits? Is there interaction between these loci? Is there interaction with dietary sugars? These loci individually, and in an interaction, are associated with type 2 diabetes–related traits; these loci also interact with dietary fructose to alter hepatic glucose uptake. Our findings support the hypothesis that these loci, coupled with dietary fructose and total sugars, alter hepatic metabolic balance and may contribute to hepatic fat and insulin resistance.
- Top Cited Papers
- 8 April 2025
- Published by American Diabetes Association in Diabetes
- Vol. 74 (7) , 1037-1046
What Is Gestational Diabetes—Really?
Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy. It is generally defined as glucose intolerance with onset or first recognition during pregnancy. The pathogenesis of GDM has long been attributed to inadequate pancreatic β-cell compensation for the physiological insulin resistance of pregnancy. This defect is thought to resolve after pregnancy but become manifest in later life as an increased risk of diabetes. Examination of mechanisms underlying GDM does not support this commonly held picture. In this Perspective, we present evidence that, like diabetes outside of pregnancy, GDM has no single etiology. It results from multiple causes of a common physiological manifestation, inadequate β-cell function, which leads to a common clinical manifestation, elevated glucose levels. We provide evidence that GDM often represents detection of chronic and progressive β-cell dysfunction that is temporally but not mechanistically related to pregnancy. We provide detailed characterization of the β-cell defect in one high-risk group, Hispanic Americans. Finally, we address some of the clinical and research implications of these findings. Article Highlights: Gestational diabetes mellitus (GDM) is not one disease but many that share inadequate β-cell function as a common cause for elevated glucose levels. Inadequate β-cell function may result from factors that occur outside of pregnancy, such as autoimmunity, monogenic disorders, obesity, and insulin resistance. Pregnancy-specific causes may exist as well but remain to be defined. Detailed physiological studies in women with obesity reveal that inadequate β-cell function is likely a chronic condition that is detected by routine glucose screening in pregnancy and that worsens over time, leading to diabetes in later life. The authors’ studies in Hispanic patients identify obesity and insulin resistance as important causes of β-cell dysfunction, providing a rationale for treating both to prevent diabetes after GDM. Additional work is needed to define the full breadth of underlying causes of GDM as the basis for precision management during and, especially, after pregnancy.
- 8 April 2025
- Published by American Diabetes Association in Diabetes
- Vol. 74 (7) , 1037-1046
Top Cited PapersWhat Is Gestational Diabetes—Really?
Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy. It is generally defined as glucose intolerance with onset or first recognition during pregnancy. The pathogenesis of GDM has long been attributed to inadequate pancreatic β-cell compensation for the physiological insulin resistance of pregnancy. This defect is thought to resolve after pregnancy but become manifest in later life as an increased risk of diabetes. Examination of mechanisms underlying GDM does not support this commonly held picture. In this Perspective, we present evidence that, like diabetes outside of pregnancy, GDM has no single etiology. It results from multiple causes of a common physiological manifestation, inadequate β-cell function, which leads to a common clinical manifestation, elevated glucose levels. We provide evidence that GDM often represents detection of chronic and progressive β-cell dysfunction that is temporally but not mechanistically related to pregnancy. We provide detailed characterization of the β-cell defect in one high-risk group, Hispanic Americans. Finally, we address some of the clinical and research implications of these findings. Article Highlights: Gestational diabetes mellitus (GDM) is not one disease but many that share inadequate β-cell function as a common cause for elevated glucose levels. Inadequate β-cell function may result from factors that occur outside of pregnancy, such as autoimmunity, monogenic disorders, obesity, and insulin resistance. Pregnancy-specific causes may exist as well but remain to be defined. Detailed physiological studies in women with obesity reveal that inadequate β-cell function is likely a chronic condition that is detected by routine glucose screening in pregnancy and that worsens over time, leading to diabetes in later life. The authors’ studies in Hispanic patients identify obesity and insulin resistance as important causes of β-cell dysfunction, providing a rationale for treating both to prevent diabetes after GDM. Additional work is needed to define the full breadth of underlying causes of GDM as the basis for precision management during and, especially, after pregnancy.
- Open Access
- 4 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-7
Associations between perceived stress and cortisol biomarkers in predominantly Latino adolescents
The relationship between cortisol and perceived stress is poorly understood. We sought to determine whether perceived stress is associated with cortisol biomarkers in adolescents. In a sample of 229 adolescents (mean age = 15.8 years) we measured perceived stress with the 14-item Perceived Stress Scale (PSS) questionnaire, serum cortisol (sCOR), salivary Cortisol Awakening Response (CAR: 30-minute post-awakening - awakening), salivary Diurnal Cortisol Slope (DCS: evening-awakening), and total daily salivary cortisol (TDC). Multivariable linear regression was used to estimate baseline associations between PSS, TDC, and sCOR Mixed effects linear regression was used to estimate baseline associations between PSS and CAR and DCS. A twelve-week longitudinal association between PSS and cortisol biomarkers using random effects regression was tested. Analyses were adjusted for age, gender, and BMI. There were statistically significant associations between PSS and TDC (beta= -104.36 ± 34.3; p = 0.002) at baseline and between PSS and DCS at 12 weeks (beta= -0.058 ± 0.02; p = 0.01), but no association between PSS and sCOR or CAR (p > 0.26 for all) at baseline or 12-weeks. There were no associations between change in PSS and change in cortisol biomarkers longitudinally. In adolescents, perceived stress, measured by the PSS, was inconsistently associated with TDC and DCS, and consistently unassociated with CAR and sCOR. Studies reporting on PSS outcomes should exercise caution when making conclusions about cortisol biomarkers. There is a need for greater specificity of psychological stress to understand their relationship with biomarkers of stress.
- 4 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-7
Open AccessAssociations between perceived stress and cortisol biomarkers in predominantly Latino adolescents
The relationship between cortisol and perceived stress is poorly understood. We sought to determine whether perceived stress is associated with cortisol biomarkers in adolescents. In a sample of 229 adolescents (mean age = 15.8 years) we measured perceived stress with the 14-item Perceived Stress Scale (PSS) questionnaire, serum cortisol (sCOR), salivary Cortisol Awakening Response (CAR: 30-minute post-awakening - awakening), salivary Diurnal Cortisol Slope (DCS: evening-awakening), and total daily salivary cortisol (TDC). Multivariable linear regression was used to estimate baseline associations between PSS, TDC, and sCOR Mixed effects linear regression was used to estimate baseline associations between PSS and CAR and DCS. A twelve-week longitudinal association between PSS and cortisol biomarkers using random effects regression was tested. Analyses were adjusted for age, gender, and BMI. There were statistically significant associations between PSS and TDC (beta= -104.36 ± 34.3; p = 0.002) at baseline and between PSS and DCS at 12 weeks (beta= -0.058 ± 0.02; p = 0.01), but no association between PSS and sCOR or CAR (p > 0.26 for all) at baseline or 12-weeks. There were no associations between change in PSS and change in cortisol biomarkers longitudinally. In adolescents, perceived stress, measured by the PSS, was inconsistently associated with TDC and DCS, and consistently unassociated with CAR and sCOR. Studies reporting on PSS outcomes should exercise caution when making conclusions about cortisol biomarkers. There is a need for greater specificity of psychological stress to understand their relationship with biomarkers of stress.
- 1 February 2023
- Published by SAGE Publications in Journal of Integrative and Complementary Medicine
- Vol. 29 (2) , 69-79
Mind- and Body-Based Interventions Improve Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Aims/Hypothesis: Only 51% of patients with type 2 diabetes achieve the hemoglobin A1c (HbA1c) Methods: The authors conducted a literature search of Ovid MEDLINE, Embase, and ClinicalTrials.gov seeking through June 10, 2022, published articles on mind and body practices and type 2 diabetes. Two reviewers independently appraised full text of articles. Only intervention studies were included. Reviewers extracted data for meta-analysis. Restricted maximum likelihood random-effects modeling was used to calculate the mean differences and summary effect sizes. The authors assessed heterogeneity using Cochran's Q and I2 statistics. Funnel plots were generated for each outcome to gauge publication bias. Weighted linear models were used to conduct study-level meta-regression analyses of practice frequency. Results: The authors identified 587 articles with 28 meeting the inclusion criteria. A statistically significant and clinically relevant mean reduction in HbA1c of −0.84% (95% confidence interval [CI]: −1.10% to −0.58%; p < 0.0001) was estimated. Reduction was observed in all intervention subgroups: mindfulness-based stress reduction: −0.48% (95% CI: −0.72% to −0.23%; p = 0.03), qigong: −0.66% (95% CI: −1.18% to −0.14%; p = 0.01), and yoga: −1.00% (95% CI: −1.38% to −0.63%; p < 0.0001). Meta-regression revealed that for every additional day of yoga practice per week, the raw mean HbA1c differed by −0.22% (95% CI: −0.44% to −0.003%; p = 0.046) over the study period. FBG significantly improved following mind and body practices, with overall mean difference of −22.81 mg/dL (95% CI: −33.07 to −12.55 mg/dL; p < 0.0001). However, no significant association was found between the frequency of weekly yoga practice and change in FBG over the study period. Conclusions/Interpretation: Mind and body practices are strongly associated with improvement in glycemic control in patients with type 2 diabetes. The overall mean reduction in HbA1c and FBG was clinically significant, suggesting that mind and body practices may be an effective, complementary nonpharmacological intervention for type 2 diabetes. Additional analyses revealed that the mean decrease in HbA1c was greater in studies requiring larger number of yoga practice sessions each week.
- 1 February 2023
- Published by SAGE Publications in Journal of Integrative and Complementary Medicine
- Vol. 29 (2) , 69-79
Mind- and Body-Based Interventions Improve Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Aims/Hypothesis: Only 51% of patients with type 2 diabetes achieve the hemoglobin A1c (HbA1c) Methods: The authors conducted a literature search of Ovid MEDLINE, Embase, and ClinicalTrials.gov seeking through June 10, 2022, published articles on mind and body practices and type 2 diabetes. Two reviewers independently appraised full text of articles. Only intervention studies were included. Reviewers extracted data for meta-analysis. Restricted maximum likelihood random-effects modeling was used to calculate the mean differences and summary effect sizes. The authors assessed heterogeneity using Cochran's Q and I2 statistics. Funnel plots were generated for each outcome to gauge publication bias. Weighted linear models were used to conduct study-level meta-regression analyses of practice frequency. Results: The authors identified 587 articles with 28 meeting the inclusion criteria. A statistically significant and clinically relevant mean reduction in HbA1c of −0.84% (95% confidence interval [CI]: −1.10% to −0.58%; p < 0.0001) was estimated. Reduction was observed in all intervention subgroups: mindfulness-based stress reduction: −0.48% (95% CI: −0.72% to −0.23%; p = 0.03), qigong: −0.66% (95% CI: −1.18% to −0.14%; p = 0.01), and yoga: −1.00% (95% CI: −1.38% to −0.63%; p < 0.0001). Meta-regression revealed that for every additional day of yoga practice per week, the raw mean HbA1c differed by −0.22% (95% CI: −0.44% to −0.003%; p = 0.046) over the study period. FBG significantly improved following mind and body practices, with overall mean difference of −22.81 mg/dL (95% CI: −33.07 to −12.55 mg/dL; p < 0.0001). However, no significant association was found between the frequency of weekly yoga practice and change in FBG over the study period. Conclusions/Interpretation: Mind and body practices are strongly associated with improvement in glycemic control in patients with type 2 diabetes. The overall mean reduction in HbA1c and FBG was clinically significant, suggesting that mind and body practices may be an effective, complementary nonpharmacological intervention for type 2 diabetes. Additional analyses revealed that the mean decrease in HbA1c was greater in studies requiring larger number of yoga practice sessions each week.
- Open Access
- 8 February 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-2
Publisher Correction: Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability
A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-21276-3
- 8 February 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-2
Open AccessPublisher Correction: Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability
A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-21276-3
- Open Access
- 5 January 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-18
Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability
Differences between sexes contribute to variation in the levels of fasting glucose and insulin. Epidemiological studies established a higher prevalence of impaired fasting glucose in men and impaired glucose tolerance in women, however, the genetic component underlying this phenomenon is not established. We assess sex-dimorphic (73,089/50,404 women and 67,506/47,806 men) and sex-combined (151,188/105,056 individuals) fasting glucose/fasting insulin genetic effects via genome-wide association study meta-analyses in individuals of European descent without diabetes. Here we report sex dimorphism in allelic effects on fasting insulin atIRS1andZNF12loci, the latter showing higher RNA expression in whole blood in women compared to men. We also observe sex-homogeneous effects on fasting glucose at seven novel loci. Fasting insulin in women shows stronger genetic correlations than in men with waist-to-hip ratio and anorexia nervosa. Furthermore, waist-to-hip ratio is causally related to insulin resistance in women, but not in men. These results position dissection of metabolic and glycemic health sex dimorphism as a steppingstone for understanding differences in genetic effects between women and men in related phenotypes.
- 5 January 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-18
Open AccessSex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability
Differences between sexes contribute to variation in the levels of fasting glucose and insulin. Epidemiological studies established a higher prevalence of impaired fasting glucose in men and impaired glucose tolerance in women, however, the genetic component underlying this phenomenon is not established. We assess sex-dimorphic (73,089/50,404 women and 67,506/47,806 men) and sex-combined (151,188/105,056 individuals) fasting glucose/fasting insulin genetic effects via genome-wide association study meta-analyses in individuals of European descent without diabetes. Here we report sex dimorphism in allelic effects on fasting insulin atIRS1andZNF12loci, the latter showing higher RNA expression in whole blood in women compared to men. We also observe sex-homogeneous effects on fasting glucose at seven novel loci. Fasting insulin in women shows stronger genetic correlations than in men with waist-to-hip ratio and anorexia nervosa. Furthermore, waist-to-hip ratio is causally related to insulin resistance in women, but not in men. These results position dissection of metabolic and glycemic health sex dimorphism as a steppingstone for understanding differences in genetic effects between women and men in related phenotypes.
- Top Cited PapersOpen Access
- 1 January 2021
- Published by Elsevier in Journal of Hepatology
- Vol. 74 (1) , 20-30
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis
- 1 January 2021
- Published by Elsevier in Journal of Hepatology
- Vol. 74 (1) , 20-30
Top Cited PapersOpen Accessrs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis
- 3 June 2019
- Published by Elsevier
- p. 563-571
Pharmacoepigenetics in Type 2 Diabetes Mellitus
- 9 February 2018
- Published by Springer Nature
- Vol. 1706, 323-351
Physiologic Interpretation of GWAS Signals for Type 2 Diabetes
This chapter reviews both statistical and physiologic issues related to the pathophysiologic effects of genetic variation in the context of type 2 diabetes. The goal is to review current methodologies used to analyze disease-related quantitative traits for those who do not have extensive quantitative and physiologic background, as an attempt to bridge that gap. We leverage mathematical modeling to illustrate the strengths and weaknesses of different approaches and attempt to reinforce with real data analysis. Topics reviewed include phenotype selection, phenotype specificity, multiple variant analysis via the genetic risk score, and consideration of multiple disease-related phenotypes. Type 2 diabetes is used as the example, not only because of the extensive existing knowledge at the genetic, physiologic, clinical, and epidemiologic levels, but also because type 2 diabetes has been at the forefront of complex disease genetics, with many examples to draw from.
- 9 February 2018
- Published by Springer Nature
- Vol. 1706, 323-351
Physiologic Interpretation of GWAS Signals for Type 2 Diabetes
This chapter reviews both statistical and physiologic issues related to the pathophysiologic effects of genetic variation in the context of type 2 diabetes. The goal is to review current methodologies used to analyze disease-related quantitative traits for those who do not have extensive quantitative and physiologic background, as an attempt to bridge that gap. We leverage mathematical modeling to illustrate the strengths and weaknesses of different approaches and attempt to reinforce with real data analysis. Topics reviewed include phenotype selection, phenotype specificity, multiple variant analysis via the genetic risk score, and consideration of multiple disease-related phenotypes. Type 2 diabetes is used as the example, not only because of the extensive existing knowledge at the genetic, physiologic, clinical, and epidemiologic levels, but also because type 2 diabetes has been at the forefront of complex disease genetics, with many examples to draw from.